Format

Send to

Choose Destination
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:69-73. doi: 10.1002/ijgo.12193.

The investment case for cervical cancer elimination.

Author information

1
PATH, Seattle, WA, USA.
2
Department of Population Health, NYU School of Medicine, Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.

Abstract

We already know what causes cervical cancer, how to prevent it, and how to treat it, even in resource-constrained settings. Inequitable access to human papillomavirus vaccine for girls and screening and precancer treatment for women in low- and middle-income countries is unacceptable on ethical, social, and financial grounds. The burden of cervical cancer falls on the poor and extends beyond the narrow bounds of the family, affecting national economic development and community life, as family resources are drained and poverty tightens its grip. Proven solutions are available and the priorities for the next few years are clear, as shown by the papers in this Supplement. Sustained political commitment and strategic investments in cervical cancer prevention can not only save millions of lives over the next 10 years, but can also pave the way for the broader fight against all cancers.

KEYWORDS:

Cervical cancer; Disease elimination; Low-income countries; Prevention

PMID:
28691328
DOI:
10.1002/ijgo.12193
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center